Ignite Creation Date:
2024-05-06 @ 2:49 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04439305
Status:
WITHDRAWN
Last Update Posted:
2020-07-20
First Post:
2020-06-18
Brief Title:
Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes MATCH-Subprotocol X
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-07
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2020-06-18
First Submit QC Date:
June 18 2020
Study First Post Date:
2020-06-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-17
Last Update Post Date:
2020-07-20
Last Update Post Date Type:
ACTUAL